Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of Recombinant Human Hyaluronidase is Effective for the Use of Local Blocks for Eyelid Surgery

NCT02059694 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02059694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02059694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of Recombinant Human Hyaluronidase is Effective for the Use of Local Blocks for Eyelid Surgery
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper eyelid surgery